Jimmy Wei
Geen lopende functies
Profiel
Jimmy Wei worked as Vice President at WI Harper Group, Inc., SVP-Business Development & Corporate Planning at Hutchison MediPharma Ltd., and Deputy General Manager at Burrill China Group.
He holds an MBA from the University of Virginia and a doctorate from North Carolina State University.
Eerdere bekende functies van Jimmy Wei
| Bedrijven | Functie | Einde |
|---|---|---|
WI Harper Group, Inc.
 WI Harper Group, Inc. Investment ManagersFinance WI Harper Group, Inc. (WI Harper) is a venture capital firm founded in 1993 by Peter Liu. The firm is headquartered in San Francisco, California with additional offices in Beijing and Taipei. | Private Equity Analist | 31-12-2007 |
| Burrill China Group | Corporate Officer/Principal | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Opleiding van Jimmy Wei
| University of Virginia | Masters Business Admin |
| North Carolina State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
WI Harper Group, Inc.
WI Harper Group, Inc. Investment ManagersFinance WI Harper Group, Inc. (WI Harper) is a venture capital firm founded in 1993 by Peter Liu. The firm is headquartered in San Francisco, California with additional offices in Beijing and Taipei. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Burrill China Group |
